NCT02988141View on ClinicalTrials.gov

EGFR-TKI Resistance Profile in Chinese Patients With Advanced EGFRm+ NSCLC

UnknownOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

March 31, 2017

Primary Completion Date

December 31, 2020

Study Completion Date

February 28, 2021

Conditions
Nonsmall Cell Lung Cancer
Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

Jianxing He

OTHER